Somatostatin (SRIF) and its receptors (SSTR) are key players in the regulation of neuroendocrine neoplasms (NEN), with significant implications for diagnosis, prognosis and treatment. The field of SSTR-targeted drugs/ligands (SRL) is continuously evolving, wit... ...

请注册登录后继续浏览